1-6 of 6
Kazuo Kasahara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO-024: Paclitaxel induced apoptosis through ROS production and eliminated cellular senescence in PC9-MET cells

Md Mohiuddin, Kazuo Kasahara
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PO-024.
https://doi.org/10.1158/1557-3265.RADSCI21-PO-024
Published: 15 April 2021
View articletitled, Abstract PO-024: Paclitaxel induced apoptosis through ROS production and eliminated cellular senescence in PC9-MET cells
Journal Articles

Abstract P27: Effect of paclitaxel in gefitinib-resistant non-small cell lung cancer (NSCLC) treatment during the COVID-19 pandemic

Md Mohiuddin, Kazuo Kasahara
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (6_Supplement): P27.
https://doi.org/10.1158/1557-3265.COVID-19-21-P27
Published: 15 March 2021
View articletitled, Abstract P27: Effect of paclitaxel in gefitinib-resistant non-small cell lung cancer (NSCLC) treatment during the COVID-19 pandemic
Journal Articles

Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non–Small Cell Lung Cancer

Jhanelle E. Gray, Isamu Okamoto, Virote Sriuranpong, Johan Vansteenkiste, Fumio Imamura, Jong Seok Lee, Yong-Kek Pang, Manuel Cobo, Kazuo Kasahara, Ying Cheng, Naoyuki Nogami, Eun Kyung Cho, Wu Chou Su, Guili Zhang, Xiangning Huang, Xiaocheng Li-Sucholeiki, Brian Lentrichia, Simon Dearden, Suzanne Jenkins, Matilde Saggese, Yuri Rukazenkov, Suresh S. Ramalingam
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22): 6644–6652.
https://doi.org/10.1158/1078-0432.CCR-19-1126
Published: 15 November 2019
View articletitled, Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non–Small Cell Lung Cancer
Open the PDF for Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Detection of Epidermal Growth Factor Receptor Mutations in Serum DNA Using the Scorpion ARMS in Patients with Advanced Non-Small-Cell Lung Cancer

Isamu Okamoto, Hideharu Kimura, Kazuo Kasahara, Kazuto Nishio
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19_Supplement): PL01-03.
Published: 15 August 2014
View articletitled, Detection of Epidermal Growth Factor Receptor Mutations in Serum DNA Using the Scorpion ARMS in Patients with Advanced Non-Small-Cell Lung Cancer
Journal Articles

Impact of Serum Hepatocyte Growth Factor on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non–Small Cell Lung Adenocarcinoma

Kazuo Kasahara, Tokuzo Arao, Kazuko Sakai, Kazuko Matsumoto, Asao Sakai, Hideharu Kimura, Takashi Sone, Atsushi Horiike, Makoto Nishio, Tatsuo Ohira, Norihiko Ikeda, Takeharu Yamanaka, Nagahiro Saijo, Kazuto Nishio
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (18): 4616–4624.
https://doi.org/10.1158/1078-0432.CCR-10-0383
Published: 14 September 2010
View articletitled, Impact of Serum Hepatocyte Growth Factor on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non–Small Cell Lung Adenocarcinoma
Open the PDF for Impact of Serum Hepatocyte Growth Factor on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non–Small Cell Lung Adenocarcinoma in another window
Journal Articles

Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung Cancer

Hideharu Kimura, Kazuo Kasahara, Makoto Kawaishi, Hideo Kunitoh, Tomohide Tamura, Brian Holloway, Kazuto Nishio
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (13): 3915–3921.
https://doi.org/10.1158/1078-0432.CCR-05-2324
Published: 03 July 2006
View articletitled, Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung Cancer
Open the PDF for Detection of Epidermal Growth Factor Receptor Mutations in Serum as a Predictor of the Response to Gefitinib in Patients with Non–Small-Cell Lung Cancer in another window